Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Developments in Wound Management Could Revolutionize Traditional Practices

By HospiMedica International staff writers
Posted on 28 Jul 2009
Understanding the problems caused by the infection of surgical wounds and their associated health implications in terms of quandaries that impose severe demands on healthcare resources could provide an alternative to traditional wound healing practices.

To address these issues, and others affecting wound management, the Royal Pharmaceutical Society of Great Britain (RPSGB, London, United Kingdom) is holding a special one-day conference on recent developments in wound management, including new intelligent biomaterials and novel antimicrobials. More...
The conference aims to deliver world-class research solutions to strategic wound management and will bring delegates up to date with recent developments in this field. Other topics and presentations to be discussed at the conference include novel antimicrobial materials, devices such as drug eluting stents and catheters, along with developments in biomaterial design. The conference is aimed at academic, industrial, and regulatory scientists working in biomaterials, synthetic chemistry, natural products, devices, and formulation development, in addition to pharmaceutical and medial microbiologists. The conference is set to take place on September 24, 2009, at the headquarters of the RPSGB in London (UK).

"Devices such as central venous catheters, sutures and dressings can be designed to release antimicrobials and provide protection from associated infection during their lifetime, but this is impractical for long term devices. New strategies are needed to improve the current situation,” said Peter Lambert, Ph.D., a professor of microbiology at the University of Aston (Birmingham, UK), who will be presenting the keynote address at the conference. "Enhanced approaches into ways of improving wound healing practices are urgently required. Understanding the problem organisms of infection cause will improve the effectiveness of skin disinfectants used during surgical procedures.”

Related Links:

Royal Pharmaceutical Society of Great Britain
University of Aston




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.